Home / Nervous system / Oxycodone and Paracetamol
ATC N02AJ17 · Opioids in combination with non-opioid analgesics
Oxycodone and Paracetamol shortage
As of 2 Nov 2026, Oxycodone and Paracetamol has a reported shortage in 2 of the 15 countries we track (United States, Canada), covering 6 products from 2 companies.
Countries2/15
Products6packs or presentations
Companies21 listed
Short since18 Jun 202517 months ago
Earliest return20 Dec 2026company estimate
Main reasonNot stated
United States5 products shortCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
United StatesCanada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Teva TEVA · NYSE / TASE
Compared with similar medicines
ATC group N02AJ · Opioids in combination with non-opioid analgesicsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 10 mg (NDC 60951-712-70) discontinuation | Endo Pharmaceuticals, Inc. | 3 Nov 2025 | not given | Not stated |
| US | Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 2.5 mg (NDC 60951-701-70) discontinuation | Endo Pharmaceuticals, Inc. | 3 Nov 2025 | not given | Not stated |
| US | Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-70) discontinuation | Endo Pharmaceuticals, Inc. | 3 Nov 2025 | not given | Not stated |
| US | Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-85) discontinuation | Endo Pharmaceuticals, Inc. | 3 Nov 2025 | not given | Not stated |
| US | Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 7.5 mg (NDC 60951-700-70) discontinuation | Endo Pharmaceuticals, Inc. | 3 Nov 2025 | not given | Not stated |
| CA | TEVA-OXYCOCET (100,500) | TEVA CANADA LIMITED | 18 Jun 2025 | 20 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.